Evommune Inc.
EVMN | NYSE
$6.22
-$0.51 (-7.58%)
Nov 2, 2026, 12:18 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 60.03M | 48.32M | 44.06M | 26.82M | 61.84M | 5.7M | 16.25M | 16.25M |
Short-Term Investments | 140.76M | 163.15M | 105.14M | 49.24M | 24.96M | 42.71M | 55.79M | 55.79M |
Long-Term Investments | 87.21M | 96.96M | 68.9M | 1.41M | 208K | 208K | 208K | n/a |
Other Long-Term Assets | 1.27M | -2.13M | 101K | 1.16M | 61K | 61K | 61K | 269K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.45M | 4.39M | 4.28M | 4.78M | 8.1M | 5.91M | n/a | n/a |
Total Current Assets | 204.25M | 215.86M | 153.48M | 80.84M | 94.9M | 54.33M | 73.99M | 73.99M |
Property-Plant & Equipment | 9.22M | 9.57M | 2.46M | 1.13M | 1.05M | 1.42M | 1.8M | 1.8M |
Goodwill & Intangibles | n/a | 2.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 97.7M | 106.6M | 71.47M | 3.7M | 1.31M | 1.69M | 2.07M | 2.07M |
Total Assets | 301.95M | 322.46M | 224.95M | 84.54M | 96.21M | 56.02M | 76.06M | 76.06M |
Account Payables | 5.04M | 4.05M | 7.76M | 3.58M | 3.67M | 7.57M | 8.26M | 8.26M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 1.82M | 589K | 504K | 465K | 745K | n/a | n/a |
Other Current Liabilities | 3.12M | 1.3M | 4.63M | 3.48M | 3.98M | 12.63M | 12.5M | 12.13M |
Total Current Liabilities | 17.49M | 10.6M | 17.91M | 10.42M | 10.09M | 22.04M | 27.98M | 27.98M |
Long-Term Debt | n/a | n/a | n/a | 257M | 257M | 191.78M | 191.78M | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 6K | n/a | 16K |
Total Long-Term Liabilities | 6.87M | 7.3M | 1.47M | 257.27M | 257.35M | 192.21M | 192.31M | 535K |
Total Liabilities | 24.36M | 17.9M | 19.38M | 267.68M | 267.44M | 214.25M | 220.29M | 28.52M |
Total Debt | 8.11M | 9.11M | 2.06M | 257.77M | 257.82M | 192.95M | 1.02M | 1.38M |
Book Value | 277.59M | 304.56M | 205.57M | -183.14M | -171.23M | -158.24M | -144.24M | 47.54M |
Book Value Per Share | 7.68 | 9.05 | 6.52 | -5.81 | -5.69 | -5.26 | -4.80 | 1.58 |
Common Stock | 4K | 4K | 3K | n/a | n/a | 1K | 1K | 1K |
Retained Earnings | -275.01M | -242.76M | -221.09M | -192.82M | -180.34M | -166.78M | -152.22M | -152.22M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 277.59M | 304.56M | 205.57M | -183.14M | -171.23M | -158.24M | 47.54M | 47.54M |
Total Investments | 227.97M | 260.1M | 174.04M | 50.66M | 25.17M | 42.92M | 55.79M | 55.79M |
Add to Watchlist
Select watchlists to add or remove EVMN